Frequently Asked Questions
The market is segmented based on , By Type (Oral Corticosteriods, Intravenous Corticosteriods), Applications (Paediatric Use, Geriatric Use), End-User (Hospitals, Research Institutes, Specialty Clinics), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2030.
.
The Global Optic Neuritis Market size was valued at USD 204.90 USD Million in 2022.
The Global Optic Neuritis Market is projected to grow at a CAGR of 5% during the forecast period of 2023 to 2030.
The major players operating in the market include Aerie Pharmaceuticals, Abbvie, Bausch Health Companies, Merck & Co, Pfizer, Teva Pharmaceutical Industries, EyePoint Pharmaceuticals, Amorphex Therapeutics Holdings, Kubota Vision, Alcon Vision, Ellex Medical, Lumenis Be, Acorn Biomedical, Astellas Pharma, Glenmark Pharmaceuticals, Bayer, Novartis.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
